EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Outcomes of surgical treatment in 115 patients with primary cardiac tumours: a 15-year experience at a single institution



Outcomes of surgical treatment in 115 patients with primary cardiac tumours: a 15-year experience at a single institution



Journal of Thoracic Disease 9(9): 2935-2941



Primary cardiac tumours are rare, and few studies have examined large samples. The aim of this study was to review a single institution's 15 years of experience with primary cardiac tumours. We conducted a retrospective analysis of 119 consecutive patients admitted to the Nanjing Drum Tower Hospital from April 2002 to January 2017. Five patients declined surgery due to illness or for financial reasons, and one patient underwent a second operation due to tumour recurrence 10 years after the first operation. In total, 115 patients underwent surgery. The surgeons used median sternotomy and a right atrial approach to complete the gross total resection. The patients were separated into three groups according to their tumour pathology (myxomas, other benign tumours, or malignant tumours). A total of 84 patients were followed up for an average of 34.8±31.2 months (range 2-141 months). The sites of the cardiac tumours included the left atrium (n=93, 80.1%), right atrium (n=14, 14.0%), left ventricle (n=2, 1.7%), valves (n=7, 6.0%), and other sites (n=1, 0.8%). According to the postoperative pathology, 99 (86.0%) tumours were classified as myxomas, 8 (7.0%) were other types of benign tumours, and 8 (7.0%) were malignant tumours. Patients with malignant tumours had a longer surgical time (P=0.035) and postoperative hospitalization time (P=0.009). Patients with myxoma tumours exhibited better 5-year survival than patients with malignant tumours (95.7% vs. 57.1%, P<0.001). In the Chinese population, the incidence of primary cardiac tumours is mainly attributable to myxomas. Gross total resection is a safe and effective treatment for both benign and malignant tumours. Long-term survival is satisfactory for benign tumours but low for malignant tumours, and a risk of recurrence exists. Postoperative chemotherapy or radiotherapy may be needed to achieve better outcomes.

(PDF emailed within 0-6 h: $19.90)

Accession: 065381501

Download citation: RISBibTeXText

PMID: 29221265

DOI: 10.21037/jtd.2017.08.04



Related references

Surgical Experience of Primary Cardiac Tumor: Single-Institution 23-Year Report. Medical Science Monitor 23: 2111-2117, 2018

Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience. Annals of Thoracic Surgery 101(2): 698-702, 2016

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience. World Journal of Urology 36(7): 1093-1101, 2018

Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Human Pathology 39(6): 933-938, 2008

Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. Journal of Gastrointestinal Surgery 16(9): 1672-1679, 2013

Short-Term Surgical Outcomes and Experience with 925 Patients Undergoing Robotic Cholecystectomy During A 4-Year Period At A Single Institution. Hepato-Gastroenterology 62(139): 573-576, 2016

Surgical Outcomes and Predicting Factors of Curative Resection in Patients with Hilar Cholangiocarcinoma 1-Year Single-Institution Experience. 2012

1114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma--a 30-year single institution experience. Hepato-Gastroenterology 48(41): 1222-1226, 2001

Cardiac Angiosarcoma Management and Outcomes 2-Year Single-institution Experience. 2012

Cardiac angiosarcoma management and outcomes: 20-year single-institution experience. Annals of Surgical Oncology 19(8): 2707-2715, 2013

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience. Gynecologic Oncology 119(2): 259-264, 2010

Surgical outcomes in Alagille syndrome and PFIC: A single institution's 20-year experience. Journal of Pediatric Surgery 53(5): 976-979, 2018

Primary cardiac tumours: a single-center 41-year experience. Isrn Cardiology 2012: 906109-906109, 2012

Clinical Characteristics and Treatment Outcomes of Patients with Primary Mediastinal Germ Cell Tumors: 10-Years' Experience at a Single Institution with a Bleomycin-Containing Regimen. Oncology Research and Treatment 39(11): 688-694, 2016

Outcomes of the Surgical Treatment for Adenocarcinoma of the Cardia - Single Institution Experience. Radiology and Oncology 52(1): 65-74, 2018